<p class="abstract"><strong>Background:</strong> Bilateral recurrent laryngeal nerve injury is mostly iatrogenic following thyroidectomy. Our study aims at defining need for tracheostomy, timing of intervention and best method to achieve permanent treatment in cases of iatrogenic bilateral recurrent laryngeal nerve.</p><p class="abstract"><strong>Methods:</strong> In past four years we did 34 total thyroidectomy surgeries, all patients were female between 21-65 years of age. Common indications were multi nodular goiter 25 cases, papillary carcinoma thyroid 7 cases and follicular neoplasm 2 cases. 5 patients developed bilateral recurrent laryngeal nerve injury, of which 3 were multi nodular goiter cases and papillary carcinoma thyroid 2 cases.  </p><p class="abstract"><strong>Results:</strong> 5 out of 34 (14.7%) patients developed bilateral recurrent laryngeal nerve injury. 3 patients had complete bilateral abductor paralysis. 1 patient had bilateral abductor paresis and 1 patient had all bilateral recurrent laryngeal nerve and superior laryngeal nerve injury causing combined paralysis of vocal cord. Other 3 patients with bilateral abductor paralysis, 1 patient was not willing for tracheostomy and 2 patients underwent tracheostomy. Of those with tracheostomy, one had partial recovery after one year and tracheostomy was removed. The other patient had coblation arytenoidectomy.</p><p class="abstract"><strong>Conclusions:</strong> In bilateral recurrent laryngeal nerve injury, Tracheostomy to be done if airway is compromised. Patients with pathological laryngeal electromyographic findings at least two months after the paresis need laryngeal framework surgery. Endoscopic cordotomy is the preferred intervention for long-term management.</p>

Introduction This prospective cohort study aims to analyze and compare the outcomes of ossiculoplasty in terms of hearing results, intra and post operative course, using autograft incus and titanium middle ear prosthesis. Materials and Methods Patients with a history of chronic ear discharge and conductive deafness were included in the study. Out of 21 patients with ossicular chain defect included in the study, 10 patients underwent ossiculoplasty with autograft incus and 11 with titanium prosthesis. Pure tone audiogram was done after three months. Result In patients with incus ossiculoplasty, average Post operative PTA was 43.5 dB ± 7.934SD and Net gain in hearing was 10.7 decibels ± 15.478SD. In patients with titanium prosthesis ossiculoplasty, average Post operative PTA was 41.4 dB ± 4.789SD and Net gain in hearing was 16 decibels ± 11.981SD. Discussion Three patients underwent only Tympanoplasty post operative PTA was 42 ± 5.292 dB (incus- 39 dB, titanium- 48dB) and hearing gain was 13.33 ± 12.583 (incus-20dB, titanium-0dB). Five patients underwent intact canal wall with Tympanoplasty: Post operative PTA was 35 ± 3 dB (incus-35dB, titanium-30dB) and hearing gain was 23 ± 15.379 (incus-18.33dB, titanium-30dB). Thirteen patients underwent canal wall down procedure with Tympanoplasty: Post operative PTA was 45.67 ± 5.228 dB (incus-50.4dB, titanium-41.8dB) and hearing gain was 9.33 ± 12.309 (incus-2.4dB, titanium-14.285dB). Complications in the short period studied were nil in both groups. Conclusion Incus and titanium have equal postoperative hearing but in terms of hearing gain Titanium prosthesis gave a better hearing gain than incus.

<p class="abstract">Rhino orbital mucor mycosis in covid infected patients presented a challenge in management. We tried analysing comprehensively the manifestations and management and prognosis of post COVID rhino orbito cerebral mucormycosis (ROCM) patients in our institution. Patients with symptoms of ROCM were managed according to the guidelines issued by the directorate of medical education, Tamil Nadu, India. 30 possible ROCM patients were treated so far from May 2021. Patients underwent radiological, microbiological and pathological investigation. In stage 1, nasal cavity alone was involved in 11 patients. In stage 2, paranasal sinus extension was seen in 8 patients. In stage 3, orbital extension was seen in 10 patients. In stage 4, intra cranial extension was seen in 1 patient. 10 patients were probable ROCM without microbiological or pathological evidence. 20 patients had proven ROCM. They were treated with endoscopic debridement. Out of them 10 patients had to undergo orbital decompression and 5 of them had improvement in vision. All proven ROCM patients were treated with 3 weeks of injection liposomal amphotericin B along with oral posaconazole 300 mg for 3-6 weeks. Post-operative histopathology noted fungal invasion of blood vessels in 19 cases and thrombus in 10 cases of orbital involvement. No mortality was reported in the study group. COVID variant associated thrombosis may be the reason for increased incidence of mucor mycosis in post COVID patients. Team work, appropriate guidelines and adequate supply of medications helped in achieving desired outcome.</p>